Grant S - Search Results

1

Histone deacetylase inhibitors in cancer therapy.

Rosato RR, Grant S. Rosato RR, et al. Among authors: grant s. Cancer Biol Ther. 2003 Jan-Feb;2(1):30-7. doi: 10.4161/cbt.190. Cancer Biol Ther. 2003. PMID: 12673114 Free article. Review.

2

Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.

Grant S, Jarvis WD, Swerdlow PS, Turner AJ, Traylor RS, Wallace HJ, Lin PS, Pettit GR, Gewirtz DA. Grant S, et al. Cancer Res. 1992 Nov 15;52(22):6270-8. Cancer Res. 1992. PMID: 1423273

3

Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C.

Jarvis WD, Turner AJ, Povirk LF, Traylor RS, Grant S. Jarvis WD, et al. Among authors: grant s. Cancer Res. 1994 Apr 1;54(7):1707-14. Cancer Res. 1994. PMID: 7511048

4

Ara-C: cellular and molecular pharmacology.

Grant S. Grant S. Adv Cancer Res. 1998;72:197-233. doi: 10.1016/s0065-230x(08)60703-4. Adv Cancer Res. 1998. PMID: 9338077 Review.

5

Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.

Wang Z, Van Tuyle G, Conrad D, Fisher PB, Dent P, Grant S. Wang Z, et al. Among authors: grant s. Cancer Res. 1999 Mar 15;59(6):1259-67. Cancer Res. 1999. PMID: 10096557

6

The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.

Cartee L, Wang Z, Decker RH, Chellappan SP, Fusaro G, Hirsch KG, Sankala HM, Dent P, Grant S. Cartee L, et al. Among authors: grant s. Cancer Res. 2001 Mar 15;61(6):2583-91. Cancer Res. 2001. PMID: 11289135

7

Sequence-dependent potentiation of paclitaxel-mediated apoptosis in human leukemia cells by inhibitors of the mitogen-activated protein kinase kinase/mitogen-activated protein kinase pathway.

Yu C, Wang S, Dent P, Grant S. Yu C, et al. Among authors: grant s. Mol Pharmacol. 2001 Jul;60(1):143-54. doi: 10.1124/mol.60.1.143. Mol Pharmacol. 2001. PMID: 11408609

8

Evidence of a functional role for the cyclin-dependent kinase-inhibitor p21WAF1/CIP1/MDA6 in promoting differentiation and preventing mitochondrial dysfunction and apoptosis induced by sodium butyrate in human myelomonocytic leukemia cells (U937).

Rosato RR, Wang Z, Gopalkrishnan RV, Fisher PB, Grant S. Rosato RR, et al. Among authors: grant s. Int J Oncol. 2001 Jul;19(1):181-91. doi: 10.3892/ijo.19.1.181. Int J Oncol. 2001. PMID: 11408941

9

Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells.

Dai Y, Yu C, Singh V, Tang L, Wang Z, McInistry R, Dent P, Grant S. Dai Y, et al. Among authors: grant s. Cancer Res. 2001 Jul 1;61(13):5106-15. Cancer Res. 2001. PMID: 11431348

10

Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.

Yu C, Krystal G, Varticovksi L, McKinstry R, Rahmani M, Dent P, Grant S. Yu C, et al. Among authors: grant s. Cancer Res. 2002 Jan 1;62(1):188-99. Cancer Res. 2002. PMID: 11782377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,824 results

Search Page

Filters